LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.4350
0.00 (0.00%)
At close: Feb 27, 2026
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 52.73 million as of March 2, 2026. Its market cap has increased by 20.11% in one year.
Market Cap
52.73M
Enterprise Value
74.33M
Revenue
26.80M
Ranking
n/a
PE Ratio
19.17
Stock Price
0.44
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 52.73M, a decrease of -14.50%. That is a compound annual growth rate of -5.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 52.73M | 24.29% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medexus Pharmaceuticals | 93.03M |
| Planet 13 Holdings | 77.12M |
| BioNxt Solutions | 73.88M |
| Vext Science | 62.76M |
| Decibel Cannabis Company | 57.70M |
| Leef Brands | 49.01M |
| ZYUS Life Sciences | 48.84M |
| C21 Investments | 46.62M |